Aberrant type 1 immunity drives susceptibility to mucosal fungal infections

被引:104
作者
Break, Timothy J. [1 ]
Oikonomou, Vasileios [1 ]
Dutzan, Nicolas [2 ]
Desai, Jigar, V [1 ]
Swidergall, Marc [3 ,4 ]
Freiwald, Tilo [5 ]
Chauss, Daniel [5 ]
Harrison, Oliver J. [6 ,21 ]
Alejo, Julie [7 ]
Williams, Drake W. [2 ]
Pittaluga, Stefania [7 ]
Lee, Chyi-Chia R. [7 ]
Bouladoux, Nicolas [6 ]
Swamydas, Muthulekha [1 ]
Hoffman, Kevin W. [8 ]
Greenwell-Wild, Teresa [2 ]
Bruno, Vincent M. [9 ]
Rosen, Lindsey B. [10 ]
Lwin, Wint [11 ]
Renteria, Andy [1 ]
Pontejo, Sergio M. [12 ]
Shannon, John P. [13 ]
Myles, Ian A. [14 ]
Olbrich, Peter [10 ]
Ferre, Elise M. N. [1 ]
Schmitt, Monica [1 ]
Martin, Daniel [15 ]
Barber, Daniel L. [17 ]
Solis, Norma, V [3 ]
Notarangelo, Luigi D. [18 ]
Serreze, David, V [19 ]
Matsumoto, Mitsuru [20 ]
Hickman, Heather D. [13 ]
Murphy, Philip M. [12 ]
Anderson, Mark S. [1 ]
Lim, Jean K. [8 ]
Holland, Steven M. [10 ]
Filler, Scott G. [3 ,4 ]
Afzali, Behdad [5 ]
Belkaid, Yasmine [6 ]
Moutsopoulos, Niki M. [2 ]
Lionakis, Michail S. [1 ]
机构
[1] NIAID, Fungal Pathogenesis Sect, Lab Clin Immunol & Microbiol LCIM, 9000 Rockville Pike, Bethesda, MD 20892 USA
[2] Natl Inst Dent & Craniofacial Res NIDCR, Oral Immun & Inflammat Sect, Bethesda, MD USA
[3] Harbor UCLA Med Ctr, Lundquist Inst Biomed Innovat, Torrance, CA 90509 USA
[4] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[5] NIDDK, Immunoregulat Sect, Kidney Dis Branch, Bethesda, MD USA
[6] NIAID, Metaorganism Immun Sect, Lab Immune Syst Biol, 9000 Rockville Pike, Bethesda, MD 20892 USA
[7] NCI, Lab Pathol, Ctr Canc Res, Bethesda, MD 20892 USA
[8] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA
[9] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA
[10] NIAID, Immunopathogenesis Sect, LCIM, 9000 Rockville Pike, Bethesda, MD 20892 USA
[11] Univ Calif San Francisco, Diabet Ctr, San Francisco, CA 94143 USA
[12] NIAID, Mol Signaling Sect, Lab Mol Immunol, 9000 Rockville Pike, Bethesda, MD 20892 USA
[13] NIAID, Viral Immun & Pathogenesis Unit, LCIM, 9000 Rockville Pike, Bethesda, MD 20892 USA
[14] NIAID, Epithelial Therapeut Unit, LCIM, 9000 Rockville Pike, Bethesda, MD 20892 USA
[15] NIDCR, Genom & Computat Biol Core, Bethesda, MD USA
[16] Natl Inst Deafness & Other Commun Disorders NIDCD, Genom & Computat Biol Core, Bethesda, MD USA
[17] NIAID, T Lymphocyte Biol Sect, Lab Parasit Dis, 9000 Rockville Pike, Bethesda, MD 20892 USA
[18] NIAID, Immune Deficiency Genet Sect, LCIM, 9000 Rockville Pike, Bethesda, MD 20892 USA
[19] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA
[20] Tokushima Univ, Inst Enzyme Res, Div Mol Immunol, Tokushima, Japan
[21] Benaroya Res Inst Virginia Mason, 1201 Ninth Avenge, Seattle, WA 98101 USA
关键词
CHRONIC MUCOCUTANEOUS CANDIDIASIS; STAT1; MUTATIONS; AIRE; CELLS; MICE; BACTERIAL; MODEL; AUTOIMMUNITY; RUXOLITINIB; MECHANISMS;
D O I
10.1126/science.aay5731
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Human monogenic disorders have revealed the critical contribution of type 17 responses in mucosal fungal surveillance. We unexpectedly found that in certain settings, enhanced type 1 immunity rather than defective type 17 responses can promote mucosal fungal infection susceptibility. Notably, in mice and humans with AIRE deficiency, an autoimmune disease characterized by selective susceptibility to mucosal but not systemic fungal infection, mucosal type 17 responses are intact while type 1 responses are exacerbated. These responses promote aberrant interferon-gamma (IFN-gamma)- and signal transducer and activator of transcription 1 (STAT1)-dependent epithelial barrier defects as well as mucosal fungal infection susceptibility. Concordantly, genetic and pharmacologic inhibition of IFN-gamma or Janus kinase (JAK)-STAT signaling ameliorates mucosal fungal disease. Thus, we identify aberrant T cell-dependent, type 1 mucosal inflammation as a critical tissue-specific pathogenic mechanism that promotes mucosal fungal infection susceptibility in mice and humans.
引用
收藏
页码:252 / +
页数:76
相关论文
共 74 条
  • [1] Optimization of the ligature-induced periodontitis model in mice
    Abe, Toshiharu
    Hajishengallis, George
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 2013, 394 (1-2) : 49 - 54
  • [2] Oral epithelial IL-22/STAT3 signaling licenses IL-17-mediated immunity to oral mucosal candidiasis
    Aggor, Felix E. Y.
    Break, Timothy J.
    Trevejo-Nunez, Giraldina
    Whibley, Natasha
    Coleman, Bianca M.
    Bailey, Rachel D.
    Kaplan, Daniel H.
    Naglik, Julian R.
    Shan, Wei
    Shetty, Amol C.
    McCracken, Carrie
    Durum, Scott K.
    Biswas, Partha S.
    Bruno, Vincent M.
    Kolls, Jay K.
    Lionakis, Michail S.
    Gaffen, Sarah L.
    [J]. SCIENCE IMMUNOLOGY, 2020, 5 (48)
  • [3] Emapalumab: First Global Approval
    Al-Salama, Zaina T.
    [J]. DRUGS, 2019, 79 (01) : 99 - 103
  • [4] Projection of an immunological self shadow within the thymus by the aire protein
    Anderson, MS
    Venanzi, ES
    Klein, L
    Chen, ZB
    Berzins, SP
    Turley, SJ
    von Boehmer, H
    Bronson, R
    Dierich, A
    Benoist, C
    Mathis, D
    [J]. SCIENCE, 2002, 298 (5597) : 1395 - 1401
  • [5] Multi-omits: Differential expression of IFN-γ results in distinctive mechanistic features linking chronic inflammation, gut dysbiosis, and autoimmune diseases
    Bae, Heekyong R.
    Leung, Patrick S. C.
    Hodge, Deborah L.
    Fenimore, John M.
    Jeon, Seon-Min
    Thovarai, Vishal
    Dzutsev, Amiran
    Welcher, Andrew A.
    Boedigheimer, Michael
    Damore, Michael A.
    Choi, Myung-Sook
    Fravell, Richard A.
    Trinchieri, Giorgio
    Gershwin, M. Eric
    Young, Howard A.
    [J]. JOURNAL OF AUTOIMMUNITY, 2020, 111
  • [6] An ACT1 Mutation Selectively Abolishes Interleukin-17 Responses in Humans with Chronic Mucocutaneous Candidiasis
    Boisson, Bertrand
    Wang, Chenhui
    Pedergnana, Vincent
    Wu, Ling
    Cypowyj, Sophie
    Rybojad, Michel
    Belkadi, Aziz
    Picard, Capucine
    Abel, Laurent
    Fieschi, Claire
    Puel, Anne
    Li, Xiaoxia
    Casanova, Jean-Laurent
    [J]. IMMUNITY, 2013, 39 (04) : 676 - 686
  • [7] Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2
    Bolyen, Evan
    Rideout, Jai Ram
    Dillon, Matthew R.
    Bokulich, NicholasA.
    Abnet, Christian C.
    Al-Ghalith, Gabriel A.
    Alexander, Harriet
    Alm, Eric J.
    Arumugam, Manimozhiyan
    Asnicar, Francesco
    Bai, Yang
    Bisanz, Jordan E.
    Bittinger, Kyle
    Brejnrod, Asker
    Brislawn, Colin J.
    Brown, C. Titus
    Callahan, Benjamin J.
    Caraballo-Rodriguez, Andres Mauricio
    Chase, John
    Cope, Emily K.
    Da Silva, Ricardo
    Diener, Christian
    Dorrestein, Pieter C.
    Douglas, Gavin M.
    Durall, Daniel M.
    Duvallet, Claire
    Edwardson, Christian F.
    Ernst, Madeleine
    Estaki, Mehrbod
    Fouquier, Jennifer
    Gauglitz, Julia M.
    Gibbons, Sean M.
    Gibson, Deanna L.
    Gonzalez, Antonio
    Gorlick, Kestrel
    Guo, Jiarong
    Hillmann, Benjamin
    Holmes, Susan
    Holste, Hannes
    Huttenhower, Curtis
    Huttley, Gavin A.
    Janssen, Stefan
    Jarmusch, Alan K.
    Jiang, Lingjing
    Kaehler, Benjamin D.
    Bin Kang, Kyo
    Keefe, Christopher R.
    Keim, Paul
    Kelley, Scott T.
    Knights, Dan
    [J]. NATURE BIOTECHNOLOGY, 2019, 37 (08) : 852 - 857
  • [8] Bouladoux Nicolas, 2017, Curr Protoc Immunol, V119, DOI 10.1002/cpim.34
  • [9] VT-1598 inhibits the in vitro growth of mucosal Candida strains and protects against fluconazole-susceptible and -resistant oral candidiasis in IL-17 signalling-deficient mice
    Break, Timothy J.
    Desai, Jigar V.
    Healey, Kelley R.
    Natarajan, Mukil
    Ferre, Elise M. N.
    Henderson, Christina
    Zelazny, Adrian
    Siebenlist, Ulrich
    Yates, Christopher M.
    Cohen, Oren J.
    Schotzinger, Robert J.
    Perlin, David S.
    Garvey, Edward P.
    Lionakis, Michail S.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2018, 73 (08) : 2089 - 2094
  • [10] VT-1161 protects mice against oropharyngeal candidiasis caused by fluconazole-susceptible and -resistant Candida albicans
    Break, Timothy J.
    Desai, Jigar V.
    Natarajan, Mukil
    Ferre, Elise M. N.
    Henderson, Christina
    Zelazny, Adrian M.
    Siebenlist, Ulrich
    Hoekstra, William J.
    Schotzinger, Robert J.
    Garvey, Edward P.
    Lionakis, Michail S.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2018, 73 (01) : 151 - 155